Second Malignant Neoplasms in Patients With Rhabdomyosarcoma

OBJECTIVE: Rhabdomyosarcoma (RMS) is a rare malignant tumor. The main treatment modality is comprehensive with chemotherapy, radiotherapy, and surgery. With the advancement in recent decades, patient survival has been prolonged, and long-term complications are attracting increasing attention among b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhen, Hongnan, Liu, Zhikai, Guan, Hui, Ma, Jiabin, Wang, Wenhui, Shen, Jing, Miao, Zheng, Zhang, Fuquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553267/
https://www.ncbi.nlm.nih.gov/pubmed/34722311
http://dx.doi.org/10.3389/fonc.2021.757095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553267/
https://www.ncbi.nlm.nih.gov/pubmed/34722311
http://dx.doi.org/10.3389/fonc.2021.757095

Ejemplares similares